Jorge Joven

16.6k total citations
377 papers, 12.2k citations indexed

About

Jorge Joven is a scholar working on Molecular Biology, Surgery and Clinical Biochemistry. According to data from OpenAlex, Jorge Joven has authored 377 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Molecular Biology, 82 papers in Surgery and 77 papers in Clinical Biochemistry. Recurrent topics in Jorge Joven's work include Paraoxonase enzyme and polymorphisms (72 papers), Liver Disease Diagnosis and Treatment (44 papers) and Lipoproteins and Cardiovascular Health (30 papers). Jorge Joven is often cited by papers focused on Paraoxonase enzyme and polymorphisms (72 papers), Liver Disease Diagnosis and Treatment (44 papers) and Lipoproteins and Cardiovascular Health (30 papers). Jorge Joven collaborates with scholars based in Spain, United States and Australia. Jorge Joven's co-authors include Jordi Camps, Javier A. Menéndez, Carlos Alonso‐Villaverde, Raúl Beltrán‐Debón, Antonio Segura‐Carretero, Judit Marsillach, Anna Rull, Salvador Fernández‐Arroyo, Elisabet Vilella and Natàlia Ferré and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Jorge Joven

363 papers receiving 11.8k citations

Peers

Countries citing papers authored by Jorge Joven

Since Specialization

Citations

This map shows the geographic impact of Jorge Joven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Joven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Joven more than expected).

Fields of papers citing papers by Jorge Joven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Joven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Joven. The network helps show where Jorge Joven may publish in the future.

Co-authorship network of co-authors of Jorge Joven

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Joven. A scholar is included among the top collaborators of Jorge Joven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Joven. Jorge Joven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Digital Pathology Tailored for Assessment of Liver Biopsies 2025 ·Biomedicines ·(unknown), David Parada, Jorge Joven	0
2	Retrospective Analysis of Clostridioides difficile Infection Rates and Outcomes in Hospitalized Patients during the COVID-19 Pandemic: A Unicenter Study in Reus, Spain 2024 ·Journal of Clinical Medicine ·Simona Iftimie, Ana F. López‐Azcona, (unknown), (unknown), (unknown), (unknown), (unknown), Jordi Camps, Jorge Joven, Antoni Castro	1
3	Preliminary Metabolomics Study Suggests Favorable Metabolic Changes in the Plasma of Breast Cancer Patients after Surgery and Adjuvant Treatment 2024 ·Biomedicines ·(unknown), (unknown), (unknown), (unknown), Helena Castañé, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Navita Somaiah, Jordi Camps, Jorge Joven, Meritxell Arenas	2
4	Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis 2023 ·Antioxidants ·Helena Castañé, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Daniel Del Castillo, Meritxell Arenas, Jordi Camps, Jorge Joven	5
5	Combining Semi-Targeted Metabolomics and Machine Learning to Identify Metabolic Alterations in the Serum and Urine of Hospitalized Patients with COVID-19 2023 ·Biomolecules ·Gerard Baiges‐Gayà, Simona Iftimie, Helena Castañé, Elisabet Rodríguez‐Tomàs, (unknown), Ana F. López‐Azcona, Antoni Castro, Jordi Camps, Jorge Joven	11
6	Splice variants of mitofusin 2 shape the endoplasmic reticulum and tether it to mitochondria 2023 ·Science ·Déborah Naón, María Isabel Hernández‐Álvarez, Satoko Shinjo, Miłosz Wieczór, Saška Ivanova, Olga Martins de Brito, Albert Quintana, Juan Hidalgo, Manuel Palacı́n, Pilar Aparicio, Juan Castellanos, Luis Lores, David Sebastián, Sonia Fernández‐Veledo, Joan Vendrell, Jorge Joven, Modesto Orozco, António Zorzano, Luca Scorrano	86
7	Measurement of Plasma Galectin-3 Concentrations in Patients with Catheter Infections: A Post Hoc Retrospective Cohort Study 2022 ·Diagnostics ·Simona Iftimie, Anna Hernández‐Aguilera, Ana F. López‐Azcona, Helena Castañé, Elisabet Rodríguez‐Tomàs, Gerard Baiges‐Gayà, Jordi Camps, Antoni Castro, Jorge Joven	0
8	Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells 2022 ·Cancers ·Elisabet Cuyàs, Salvador Fernández‐Arroyo, Sara Verdura, Ruth Lupu, Jorge Joven, Javier A. Menéndez	3
9	An MMP‐degraded and cross‐linked fragment of type III collagen as a non‐invasive biomarker of hepatic fibrosis resolution 2022 ·Liver International ·(unknown), Tina Manon‐Jensen, Shu Sun, Ida Falk Villesen, Helena Castañé, Jorge Joven, Keyur Patel, Zachary Goodman, Mette Juul Nielsen, Anne‐Christine Bay‐Jensen, Diana Julie Leeming, Joachim Høg Mortensen, M.A. Karsdal	16
10	Gradient Boosting Machine Identified Predictive Variables for Breast Cancer Patients Pre- and Post-Radiotherapy: Preliminary Results of an 8-Year Follow-Up Study 2022 ·Antioxidants ·Elisabet Rodríguez‐Tomàs, Meritxell Arenas, Gerard Baiges‐Gayà, (unknown), (unknown), (unknown), Helena Castañé, (unknown), (unknown), S. Sabater, Rosa Solà, Jordi Camps, Jorge Joven	6
11	Lung Cancer Management with Silibinin: A Historical and Translational Perspective 2021 ·Pharmaceuticals ·Sara Verdura, Elisabet Cuyàs, Verónica Ruiz-Torres, Vicente Micol, Jorge Joven, Joaquim Bosch‐Barrera, Javier A. Menéndez	40
12	Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview 2021 ·Biomolecules ·Helena Castañé, Gerard Baiges‐Gayà, Anna Hernández‐Aguilera, Elisabet Rodríguez‐Tomàs, Salvador Fernández‐Arroyo, Pol Herrero, (unknown), Núria Canela-Canela, Javier A. Menéndez, Jordi Camps, Jorge Joven	18
13	On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update 2021 ·Biomolecules ·Jordi Camps, Helena Castañé, Elisabet Rodríguez‐Tomàs, Gerard Baiges‐Gayà, Anna Hernández‐Aguilera, Meritxell Arenas, Simona Iftimie, Jorge Joven	25
14	Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy 2019 ·Antioxidants ·Elisabet Rodríguez‐Tomàs, M. Murcia, Meritxell Arenas, (unknown), (unknown), Núria Amigó, Xavier Correig, L. Torres, S. Sabater, Gerard Baiges‐Gayà, Noemí Cabré, Fedra Luciano‐Mateo, Anna Hernández‐Aguilera, Isabel Fort-Gallifa, Jordi Camps, Jorge Joven	17
15	Plasma Energy-Balance Metabolites Discriminate Asymptomatic Patients with Peripheral Artery Disease 2018 ·Mediators of Inflammation ·Anna Hernández‐Aguilera, Salvador Fernández‐Arroyo, Noemí Cabré, Fedra Luciano‐Mateo, Gerard Baiges‐Gayà, (unknown), Vicente Martín-Paredero, Javier A. Menéndez, Jordi Camps, Jorge Joven	9
16	Metformin directly targets the H3K27me3 demethylase KDM6A/UTX 2018 ·Aging Cell ·Elisabet Cuyàs, Sara Verdura, Laura Llorach-Parés, Salvador Fernández‐Arroyo, Fedra Luciano‐Mateo, Noemí Cabré, Jan Štursa, Lukáš Werner, Begoña Martı́n-Castillo, Benoı̂t Viollet, Jiřı́ Neužil, Jorge Joven, Alfons Nonell‐Canals, Melchor Sánchez-Martínez, Javier A. Menéndez	64
17	Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation 2017 ·International Journal of Molecular Sciences ·Isabel Fort-Gallifa, Anna Hernández‐Aguilera, Anabel García‐Heredia, Noemí Cabré, Fedra Luciano‐Mateo, Josep M. Simó, Vicente Martín-Paredero, Jordi Camps, Jorge Joven	35
18	Immunohistochemical Analysis of Paraoxonases and Chemokines in Arteries of Patients with Peripheral Artery Disease 2015 ·International Journal of Molecular Sciences ·Anna Hernández‐Aguilera, (unknown), Esther Rodríguez‐Gallego, María Guirro, Anabel García‐Heredia, Noemí Cabré, Fedra Luciano‐Mateo, Isabel Fort-Gallifa, Vicente Martín-Paredero, Jorge Joven, Jordi Camps	23
19	The mitochondrial H⁺-ATP synthase and the lipogenic switch 2013 ·Cell Cycle ·Alejandro Vázquez‐Martín, Bruna Corominas-Faja, Sílvia Cufí, Luciano Vellón, Cristina Oliveras‐Ferraros, (unknown), Jorge Joven, Ruth Lupu, Javier A. Menéndez	76
20	Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy 2006 ·European Journal of Pharmacology ·Blai Coll, J.P.H. van Wijk, Sandra Parra, Manuel Castro Cabezas, I. M. Hoepelman, Carlos Alonso‐Villaverde, Eelco J.P. de Koning, Jordi Camps, Natàlia Ferré, Ton J. Rabelink, Mònica Tous, Jorge Joven	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact